Search Results

Learn how PPD’s comprehensive, patient-centric strategies create flexibility for today’s traditional cell and gene therapy trial challenges.

Biopharma and biotech companies are turning to functional service provider (FSP) partnerships as a strategy to access the expertise and resources needed to meet their timelines. The webinar will discuss the findings of the 2024 FSP Trends Report.

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, and Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, have won a 2022 TOPRA Award for Regulatory Excellence.